Is Semaglutide Worth It For Weight Loss?

Semaglutide, marketed under the brand name Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist. Originally developed to manage type 2 diabetes, its potential for weight loss was discovered during clinical trials. This discovery has led to its approval by the FDA for chronic weight management in adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with at least one weight-related condition, such as hypertension, type 2 diabetes, or high cholesterol.